Sources: 12Gene Ontology See all sources |
Cellular components related to autoimmune thyroiditis according to GeneDecks: (show all 18)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | MHC class II protein complex | GO:042613 | 10.6 | HLA-DRB5, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DRB4, HLA-DRB3 | | 2 | clathrin-coated endocytic vesicle membrane | GO:030669 | 10.5 | HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DRA, HLA-DQB1 | | 3 | trans-Golgi network membrane | GO:032588 | 10.5 | HLA-DRB5, HLA-DRB4, HLA-DRB3, HLA-DRB1, HLA-DRA, HLA-DQB1 | | 4 | lysosomal membrane | GO:005765 | 10.5 | HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 | | 5 | transport vesicle membrane | GO:030658 | 10.5 | HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DRA, HLA-DQB1 | | 6 | endocytic vesicle membrane | GO:030666 | 10.4 | HLA-DRB5, HLA-DRB4, HLA-DRB3, HLA-DRB1, HLA-DRA, HLA-DQB1 | | 7 | late endosome membrane | GO:031902 | 10.4 | HLA-DRB4, HLA-DRB3, HLA-DRB1, HLA-DRA, HLA-DMB, HLA-DMA | | 8 | Golgi membrane | GO:000139 | 10.3 | GAD2, TLR3, HLA-F, HLA-E, HLA-DRB5, HLA-DRB4 | | 9 | integral to lumenal side of endoplasmic reticulum membrane | GO:071556 | 10.3 | HLA-G, HLA-F, HLA-E, HLA-DRB5, HLA-DRB4, HLA-DRB3 | | 10 | ER to Golgi transport vesicle membrane | GO:012507 | 10.2 | HLA-DQA2, HLA-DQA1, HLA-DPB1, HLA-DPA1, HLA-C, HLA-B | | 11 | MHC class I protein complex | GO:042612 | 10.2 | HLA-G, HLA-F, HLA-E, HLA-C, HLA-B, HLA-A | | 12 | phagocytic vesicle membrane | GO:030670 | 10.1 | HLA-G, HLA-F, HLA-E, HLA-C, HLA-B, HLA-A | | 13 | endosome membrane | GO:010008 | 9.6 | TF, TLR3, HLA-DQB1, HLA-DQA2, HLA-DQA1, HLA-DPB1 | | 14 | integral to plasma membrane | GO:005887 | 9.4 | TNF, TPO, HLA-DRB4, HLA-DRB3, HLA-DRB1, HLA-DRA | | 15 | external side of plasma membrane | GO:009897 | 9.1 | CXCL10, IL2RB, IL13, ITGAL, CD40, CD83 | | 16 | extracellular space | GO:005615 | 5.2 | ADA, ICAM1, IFNG, IFNB1, IFNA8, IFNA7 | | 17 | plasma membrane | GO:005886 | INF | HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TRH | | 18 | extracellular region | GO:005576 | INF | TSHB, IFNA8, IFNA7, IFNA6, IFNA5, IFNA4 |
Biological processes related to autoimmune thyroiditis according to GeneDecks: (show top 50)
(show all 91)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | regulation of type I interferon-mediated signaling pathway | GO:060338 | 11.0 | IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2 | | 2 | T-helper 1 type immune response | GO:042088 | 10.8 | IL18, IL12B, HLA-DRB4, HLA-DRB5, HLA-DRB3, HLA-DRB1 | | 3 | antigen processing and presentation of exogenous peptide antigen via MHC class II | GO:019886 | 10.7 | HLA-DOA, HLA-DPB1, HLA-DQB1, HLA-DOB, HLA-DPA1, HLA-DQA1 | | 4 | immunoglobulin production involved in immunoglobulin mediated immune response | GO:002381 | 10.7 | HLA-DRB5, HLA-DRB4, HLA-DRB3, HLA-DRB1, HLA-DQB1 | | 5 | type I interferon-mediated signaling pathway | GO:060337 | 10.7 | IFNA4, IFNA10, IFNA13, IFNA14, IFNA16, PSMB8 | | 6 | T cell receptor signaling pathway | GO:050852 | 10.7 | HLA-DRA, HLA-DQB1, HLA-DQA1, HLA-DPB1, HLA-DQA2, HLA-DRB5 | | 7 | humoral immune response mediated by circulating immunoglobulin | GO:002455 | 10.6 | HLA-DRB3, HLA-DQB1, HLA-DRB1, HLA-DRB5, HLA-DRB4 | | 8 | T cell costimulation | GO:031295 | 10.6 | CD28, CD86, CD80, ICOS, HLA-DPA1, HLA-DPB1 | | 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent | GO:002480 | 10.6 | HLA-E, HLA-G, HLA-F, HLA-C, HLA-B, HLA-A | | 10 | detection of bacterium | GO:016045 | 10.5 | HLA-B, HLA-DRB3, HLA-DRB4, HLA-A, HLA-DRB1, HLA-DRB5 | | 11 | cellular response to interferon-gamma | GO:071346 | 10.5 | HLA-DPA1, CCL2, TLR3, IL18, IL12B, CCL5 | | 12 | positive regulation of interleukin-12 production | GO:032735 | 10.4 | IL12B, CD40, CD40LG, IL23R, IFNG, HLA-G | | 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | GO:002479 | 10.4 | TAP2, HLA-A, TAP1, HLA-B, HLA-C, HLA-E | | 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I | GO:042590 | 10.4 | HLA-G, TAP2, PSMB8, HLA-A, HLA-B, HLA-C | | 15 | negative regulation of interferon-gamma production | GO:032689 | 10.4 | HLA-DRB3, LILRB1, FOXP3, IL10, HLA-DRB1, HLA-DRB4 | | 16 | interferon-gamma-mediated signaling pathway | GO:060333 | 10.3 | HLA-DPA1, VCAM1, IFNG, ICAM1, HLA-A, HLA-B | | 17 | antigen processing and presentation of peptide antigen via MHC class I | GO:002474 | 10.3 | HLA-F, PSMB9, TAP1, HLA-G, HLA-E, HLA-A | | 18 | defense response to virus | GO:051607 | 10.3 | CD86, CXCL10, PRF1, TLR3, IFNB1, IL6 | | 19 | positive regulation of interleukin-17 production | GO:032740 | 10.2 | IL12B, IL15, IL18, IL2, IL23R, TGFB1 | | 20 | chemotaxis | GO:006935 | 10.2 | CXCL9, IL4, CCL2, CCL20, CCL17, CCL5 | | 21 | response to virus | GO:009615 | 10.1 | IFNA7, IFNA6, IFNA5, IFNA4, IFNA21, IFNA2 | | 22 | response to lipopolysaccharide | GO:032496 | 10.1 | TNFRSF1A, SELE, IL13, IL1A, CXCL10, LTA | | 23 | leukocyte cell-cell adhesion | GO:007159 | 10.1 | VCAM1, SELE, CD40LG, ITGAL, ITGB2, CALCA | | 24 | regulation of immune response | GO:050776 | 10.1 | IL4, ICAM1, HLA-A, HLA-E, HLA-B, HLA-C | | 25 | negative regulation of T cell proliferation | GO:042130 | 10.1 | LILRB1, FOXP3, HLA-DRB5, HLA-DRB4, IL10, HLA-DRB3 | | 26 | lymph node development | GO:048535 | 10.0 | TGFB1, CXCL13, IL15, CXCR5, LTA | | 27 | cellular response to lipopolysaccharide | GO:071222 | 9.9 | TNFRSF1B, IFNG, ICAM1, LILRB1, IL10, IL12B | | 28 | negative regulation of growth of symbiont in host | GO:044130 | 9.8 | IL10, IL12B, MBL2, TNF, LTA, IFNG | | 29 | humoral immune response | GO:006959 | 9.6 | IFNG, CD83, TNF, CCL2, IFNB1, AIRE | | 30 | positive regulation of T cell proliferation | GO:042102 | 9.6 | IFNG, CCL5, IL6, IL4, IL23R, IL1B | | 31 | response to estrogen stimulus | GO:043627 | 9.6 | TSHB, FAS, GHRL, CCL5, ESR1, PTPRN | | 32 | positive regulation of B cell proliferation | GO:030890 | 9.6 | ADA, IL4, IL2, IL13, CD40, CD40LG | | 33 | B cell proliferation | GO:042100 | 9.4 | IL10, CD40, CD40LG, BCL2, IFNB1 | | 34 | aging | GO:007568 | 9.4 | ADA, IL15, IL1B, FAS, CCL2, CCL5 | | 35 | positive regulation of interferon-gamma production | GO:032729 | 9.3 | IL18, CD40LG, IL12B, IL1B, IL2, IL23R | | 36 | positive regulation of chemokine biosynthetic process | GO:045080 | 9.3 | TLR3, TNF, IL1B, IL4, IFNG | | 37 | response to drug | GO:042493 | 8.9 | ICAM1, IL4, IFNG, GPX3, CCL5, CCL2 | | 38 | response to glucocorticoid stimulus | GO:051384 | 8.7 | IL1RN, ACADS, FAS, TNF, CCL5, IL10 | | 39 | cell-cell signaling | GO:007267 | 8.6 | CXCL13, IL15, IL13, IL10, INS, AR | | 40 | MAPK cascade | GO:000165 | 8.6 | RET, INS, CCL2, TGFB1, TNF, CCL5 | | 41 | response to hypoxia | GO:001666 | 8.4 | ADA, TNFRSF1A, SRF, LTA, TGFB1, CXCL12 | | 42 | positive regulation of sequence-specific DNA binding transcription factor activity | GO:051091 | 8.1 | IL6, IL10, IL4, IL5, ESR1, ESR2 | | 43 | anti-apoptosis | GO:006916 | 8.1 | TNFRSF18, TNF, FAS, BCL2, MPO, CD40LG | | 44 | inflammatory response | GO:006954 | 6.7 | SELE, IL5, IL23R, IL1B, IL1A, IL18 | | 45 | blood coagulation | GO:007596 | INF | IFNA21, TGFB1, PPBP, IFNA16, TP53, TIMP1 | | 46 | signal transduction | GO:007165 | INF | ESR1, GAST, CCL20, CCL2, FAS, FASLG | | 47 | cytokine-mediated signaling pathway | GO:019221 | INF | PTPRN, PSMB8, HLA-G, IL6, IL5, IL2RB | | 48 | positive regulation of transcription from RNA polymerase II promoter | GO:045944 | INF | IL6, THRB, TLR3, SRF, TNFRSF1A, TP53 | | 49 | innate immune response | GO:045087 | INF | IFIH1, BCL2, IFNA13, IFNA16, IFNA10, IFNA17 | | 50 | immune response | GO:006955 | INF | CTLA4, HLA-DRB5, HLA-DRB4, HLA-DRB3, HLA-DRB1, HLA-DRA |
Molecular functions related to autoimmune thyroiditis according to GeneDecks: (show all 12)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | cytokine receptor binding | GO:005126 | 10.8 | IFNA8, IFNA6, IFNA5, IFNA21, IFNA14, IFNA10 | | 2 | MHC class II receptor activity | GO:032395 | 10.7 | HLA-DRB4, HLA-DOA, HLA-DRB3, HLA-DRB1, HLA-DRA, HLA-DQB1 | | 3 | interferon-alpha/beta receptor binding | GO:005132 | 10.6 | IFNB1, IFNA7, IFNA4, IFNA2, IFNA17, IFNA16 | | 4 | tumor necrosis factor-activated receptor activity | GO:005031 | 10.5 | FAS, TNFRSF18, TNFRSF1A, TNFRSF1B | | 5 | MHC class I receptor activity | GO:032393 | 10.3 | HLA-G, HLA-F, HLA-E, HLA-C, HLA-B, HLA-A | | 6 | peptide antigen binding | GO:042605 | 10.1 | TAP1, HLA-DRB5, HLA-DRB4, HLA-DRB3, HLA-DRB1 | | 7 | chemokine activity | GO:008009 | 10.0 | CXCL9, CXCL13, CXCL12, CXCL11, CXCL10, PPBP | | 8 | receptor binding | GO:005102 | 9.4 | HLA-B, HLA-G, LTA, PRDX5, CXCL10, CXCL12 | | 9 | protease binding | GO:002020 | 8.3 | TNFRSF1A, TNF, TP53, HSPA1B, INS, CD28 | | 10 | growth factor activity | GO:008083 | 8.0 | CXCL12, TGFB1, PPBP, IL6, IL5, IL4 | | 11 | cytokine activity | GO:005125 | 7.9 | TNF, IFNG, IFNB1, IFNA8, IFNA7, IFNA6 | | 12 | protein binding | GO:005515 | INF | TNF, TNFRSF1A, TNFRSF1B, , PTPN22, PTPN3 |
|